↓ Skip to main content

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial

Overview of attention for article published in BMC Infectious Diseases, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs
1 blog
twitter
11 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
136 Dimensions

Readers on

mendeley
240 Mendeley
Title
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
Published in
BMC Infectious Diseases, December 2020
DOI 10.1186/s12879-020-05698-w
Pubmed ID
Authors

Marzieh Nojomi, Zeynab Yassin, Hossein Keyvani, Mahin Jamshidi Makiani, Maryam Roham, Azadeh Laali, Nasir Dehghan, Mehrnaz Navaei, Mitra Ranjbar

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 240 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 240 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 27 11%
Student > Master 24 10%
Researcher 19 8%
Other 15 6%
Student > Ph. D. Student 10 4%
Other 30 13%
Unknown 115 48%
Readers by discipline Count As %
Medicine and Dentistry 34 14%
Pharmacology, Toxicology and Pharmaceutical Science 22 9%
Nursing and Health Professions 14 6%
Biochemistry, Genetics and Molecular Biology 10 4%
Chemistry 8 3%
Other 29 12%
Unknown 123 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2022.
All research outputs
#1,911,852
of 25,068,002 outputs
Outputs from BMC Infectious Diseases
#502
of 8,434 outputs
Outputs of similar age
#51,127
of 520,119 outputs
Outputs of similar age from BMC Infectious Diseases
#9
of 173 outputs
Altmetric has tracked 25,068,002 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,434 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,119 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.